{"name": "Dicerna Pharmaceuticals",
 "permalink": "dicerna-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/dicerna-pharmaceuticals",
 "homepage_url": "http://www.dicerna.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "contact@dicerna.com",
 "phone_number": "617-621-8097",
 "description": "",
 "created_at": "Tue Jan 05 10:39:33 UTC 2010",
 "updated_at": "Fri Dec 16 03:44:00 UTC 2011",
 "overview": "\u003Cp\u003EDicerna Pharmaceuticals, Inc., a biopharmaceutical company, develops therapeutic agents in various disease areas based on dicer substrate technology platform. The company offers RNA interference (RNAi)-targeted drugs and delivery systems for therapeutic areas of oncology and metabolic diseases. It also provides Dicer Substrate Technology, a second generation of gene silencing, which triggers RNAi and is used in therapeutic areas, including inflammation, immunology, and cardiovascular diseases. The company was founded in 2007 and is based in Watertown, Massachusetts.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       56],
      "assets/images/resized/0007/2125/72125v1-max-150x150.jpg"],
     [[227,
       86],
      "assets/images/resized/0007/2125/72125v1-max-250x250.jpg"],
     [[227,
       86],
      "assets/images/resized/0007/2125/72125v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Jim",
      "last_name": "Jenson",
      "permalink": "jim-jenson",
      "image": null}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Brian",
      "last_name": "K. Halak",
      "permalink": "brian-k-halak",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$153M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/dicerna-nails-down-124m-rnai-development-pact/2010-01-04?utm_medium=rss\u0026utm_source=rss\u0026cmp-id=OTC-RSS-FB0",
    "source_description": "Dicerna lands $124M RNAi development pact",
    "raised_amount": 124000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 1,
    "funded_day": 4,
    "investments":
     [{"company":
        {"name": "Kyowa Hakko Kirin",
         "permalink": "kyowa-hakko-kirin",
         "image":
          {"available_sizes":
            [[[150,
               7],
              "assets/images/resized/0007/2128/72128v1-max-150x150.png"],
             [[250,
               13],
              "assets/images/resized/0007/2128/72128v1-max-250x250.png"],
             [[357,
               19],
              "assets/images/resized/0007/2128/72128v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.fiercebiotech.com/story/dicerna-bags-25m-series-b-next-gen-rnai-work/2010-08-11?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Dicerna bags $25M Series B for next-gen RNAi work  Read more: Dicerna bags $25M Series B for next-gen RNAi work - FierceBiotech http://www.fiercebiotech.com/story/dicerna-bags-25m-series-b-next-gen-rnai-work/2010-08-11?utm_medium=rss\u0026utm_source=rss#ixzz0w",
    "raised_amount": 25000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 8,
    "funded_day": 11,
    "investments":
     []},
   {"round_code": "b",
    "source_url": "http://www.masshightech.com/stories/2010/10/18/daily46-Dicerna-makes-29M-second-close-on-Series-B-funding-round.html",
    "source_description": "Dicerna makes $29M second close on Series B funding round",
    "raised_amount": 4000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 10,
    "funded_day": 21,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "SR One",
         "permalink": "sr-one",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0004/8794/48794v2-max-150x150.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-250x250.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCare Ventures",
         "permalink": "healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/9268/49268v1-max-150x150.jpg"],
             [[250,
               34],
              "assets/images/resized/0004/9268/49268v1-max-250x250.jpg"],
             [[290,
               40],
              "assets/images/resized/0004/9268/49268v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "480 Arsenal Street",
    "address2": "Building 1, Suite 120",
    "zip_code": "02472",
    "city": "Watertown ",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Dicerna Pharmaceuticals Inc. and Japanese biopharmaceutical firm Kyowa Hakko Kirin Co. Ltd. have expanded a collaboration deal the two companies share, to include immunologic and inflammatory disease areas.",
    "stoned_year": 2010,
    "stoned_month": 12,
    "stoned_day": 7,
    "source_url": "http://www.masshightech.com/stories/2010/12/06/daily22-Dicerna-deal-with-Japanese-biotech-adds-new-drug-target.html",
    "source_text": null,
    "source_description": "Dicerna deal with Japanese biotech adds new drug target",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Dicerna Pharmaceuticals",
      "permalink": "dicerna-pharmaceuticals"}},
   {"description": "Dicerna wins $5M payment from partner KHK.",
    "stoned_year": 2011,
    "stoned_month": 12,
    "stoned_day": 15,
    "source_url": "http://www.masshightech.com/stories/2011/12/12/daily32-Dicerna-wins-5M-payment-from-partner-KHK.html",
    "source_text": "",
    "source_description": "Dicerna wins $5M payment from partner KHK",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Dicerna Pharmaceuticals",
      "permalink": "dicerna-pharmaceuticals"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0007/2124/72124v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0007/2124/72124v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0007/2124/72124v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}